Locations:
ARO-DIMER-PA is a Dual-Target RNA Therapy that targets the liver to lower two key proteins involved in high cholesterol at the same time
Phase 3 HORIZON cardiovascular outcome trial examined the safety and efficacy of pelacarsen in patients with elevated lipoprotein(a) and pre-existing cardiovascular disease
Patients achieved meaningful two-year weight loss after undergoing bariatric surgery
Study indicates common CD36 gene variant may be the leading genetic cause of dilated cardiomyopathy in this population
Innovation, treatments and breakthrough research told through the eyes of inspiring patients and doctors.
Services include fulfilling requests for live, remote and pre-recorded interviews, as well as providing a range of assets such as infographics, photos and b-roll footage.
Search